Harvard Department of Stem Cell and Regenerative Biology Howard Hughes Medical Institute
Doug Melton's goal is to cure diabetes. His lab is working to eliminate the present practice of regular blood checks and insulin injections, replacing...
In spring, 2017, Khalid Shah and Tracy Young-Pearse were settled in their new research home in Brigham and Women’s ‘Building for Transformative Medicine’ on Fenwood Road. Like good neighbors, they were very eager to get to know their HSCI colleagues in the Longwood area. With the HIP interns about to arrive, they figured, why not build a community around these new arrivals to our research family?
Khalid and Tracy thus organized three meetings over the summer of 2017 bringing together HSCI PIs in the Longwood area along with their HIP interns. The PIs came to know each other...
Group photo at the semi-annual meeting of the joint steering committee of the HSCI’s collaboration with Boehringer Ingelheim in fibrosis research with the research project teams.
The Harvard Stem Cell Institute (HSCI) Blood Program invites applications for its 2017-2018 Pilot Grant cycle. The purpose of this funding program is to provide resources for projects in the field of blood stem cell biology with a basic, translational, or clinical research focus. HSCI is seeking to fund groundbreaking, innovative, high-impact research projects that could fundamentally enhance biomedical research in the field. Of particular interest to HSCI at this time is research...
The inner lining of the gut consists of a single cell layer of intestinal epithelium that form millions of crypts and villi. Stem cells – shown in green – reside at the bottom of the crypts and...
We are proud to announce that Ya-Chieh Hsu, PhD, has been selected by the Pew Charitable Trust to receive an early-career award that will fund her research for the next four years.
Hsu joined the Harvard Department of Stem Cell and Regenerative Biology (HSCRB) as an assistant professor in 2014, at which time she also became Principal Faculty at the Harvard Stem Cell Institute. Her research is focused on uncovering the function and potential of transit-amplifying skin cells, which play a key role in tissue development, regeneration, and are especially sensitive to chemotherapy drugs. Understanding the role these cells play in skin regeneration could lead to the development of therapies that alleviate or prevent some of the side effects of chemotherapy, such as hair loss and compromised wound healing.
We asked Hsu to share her impressions upon receiving the award.
Adapted from a Boston Children's Hospital press release.
Two golden retrievers that had the genetic mutation for Duchenne muscular dystrophy (DMD), yet remained healthy, have offered up yet another lead for treating this muscle-wasting disorder.
We are proud to announce that